BioSpace News Archive

Conference Call and Webcast to Follow at 5:00 p.m. EST/ 2:00 p.m. PST

BIOASIS TECHNOLOGIES INC. announced that it has filed its unaudited quarterly financial statements and management’s discussion and analysis for the period ended Nov. 30, 2018.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) and Voyager Therapeutics, Inc. (NASDAQ: VYGR), today announced the formation of a strategic collaboration focused on the development and commercialization of Voyager’s gene therapy programs, VY-AADC for Parkinson’s disease and VY-FXN01 for Friedreich’s ataxia, as well as rights to two programs to be determined.

In recognition of its dedication to advocating for customers, Integrated DNA Technologies (IDT), has won a prestigious Life Science Industry Award for Best Overall Customer Experience, as well as a Gold award for Most Useful Website.

TrakCel, today announce they have partnered to build a custom-configured cellular supply chain tracking and orchestration platform to support clinical development of proprietary autologous cell therapies by WindMIL.

EKF Diagnostics, the global in vitro diagnostics company, announces that it has signed a private label distribution agreement with McKesson Medical-Surgical Inc. for the Company’s hand-held reagent-free hemoglobin analyzer, the DiaSpect Tm

Life science marketing communications agency BioStrata has announced a series of new appointments this quarter, as part of its ongoing strategy to further develop its specialist services across public relations and inbound marketing. All five new hires will be based out of BioStrata’s UK headquarters in Cambridge, although its team also spans North America and mainland Europe.

First in Human Stem Cell Trial for Hemodialysis AVF Yields Promising Results

HOX Therapeutics, the private biotechnology company developing first-in-class, highly targeted cancer therapies based on HOX genes, announces the appointment of Dr Stephen Shuttleworth as Non-Executive Director.

Qualigen, Inc. announced that the Company has received clearance from the U.S. Food and Drug Administration for its FastPack IP Sex Hormone Binding Globulin Immunoassay.